Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
32.75 USD | +4.63% | +2.55% | -0.20% |
11:38am | Truist Adjusts Price Target on Corcept Therapeutics to $65 From $44, Maintains Buy Rating | MT |
May. 28 | Sector Update: Health Care Stocks Retreat Tuesday Afternoon | MT |
Turnover - Change in analysts' estimates
Earnings Per Share (EPS) - Change in analysts' estimates
EBIT - Change in analysts' estimates
Turnover
Earnings Per Share (EPS)
EBIT
- Stock Market
- Equities
- CORT Stock
- Revisions Corcept Therapeutics Incorporated